drug
-
Technology
Most powerful obesity drug yet: People lost up to 25% of weight in trial
The Evolution of Incretin-Based Therapies The medical community’s understanding of weight management has shifted dramatically over the last decade, moving…
Read More » -
Health
Unveiling a Hidden Regulatory Mechanism: How NUDT5 Protein Influences Leukemia Drug Resistance Beyond Traditional Enzymatic Pathways
For more than seven decades, 6-thioguanine (6-TG) has served as a cornerstone in the pharmacological arsenal against leukemia. Despite its…
Read More » -
Health
Breakthrough Experimental Drug CS18 Shows Promise in Overcoming Treatment-Resistant Cancer Cells
Researchers at Baylor College of Medicine have achieved a significant milestone in oncology by developing an experimental compound, CS18, designed…
Read More » -
Health
This new drug could break cancer’s resistance to treatment
The pursuit of durable cancer remission is frequently thwarted by the biological adaptability of malignant tumors. While initial chemotherapy, targeted…
Read More » -
Health
Trump Administration Unveils GENEROUS Model to Address Medicaid Prescription Drug Costs
WASHINGTON — In a high-profile move aimed at curbing the escalating costs of prescription medications for the nation’s most vulnerable…
Read More » -
Health
Secretive Pharmaceutical Deals Threaten to Slash Projected Savings of Trump Administration’s Medicare Drug Pricing Plan by Eighty Percent
The Trump administration’s flagship initiative to curb soaring prescription drug costs is facing significant scrutiny as a new analysis suggests…
Read More » -
Health
AstraZeneca faces a significant setback as the breast cancer drug camizestrant fails to meet primary endpoints in a pivotal first-line clinical trial.
The pharmaceutical giant AstraZeneca confirmed on Friday that its novel oral endocrine therapy, camizestrant, failed to demonstrate a superior clinical…
Read More »
